Effect of gold marker seeds on magnetic resonance spectroscopy of the prostate

International Journal of Radiation Oncology Biology Physics

Volumn 83, Issue 1, 2012, Pages 451-458

  Hossain, Murshed ^a   Schirmer, Timo ^b   Richardson, Theresa ^a   Chen, Lili ^a   Buyyounouski, Mark K ^a   Ma, Chang Ming ^a  

^a FOX CHASE CANCER CENTER   (United States)

^b GE HEALTHCARE   (Germany)

Author keywords

Gold marker seeds; Magnetic resonance spectroscopy; Prostate magnetic resonance spectroscopy

Indexed keywords

COEFFICIENT OF VARIATION; FIDUCIAL MARKER; GOLD SEEDS; IMAGE GUIDANCES; LOCAL SPECTRUM; PHANTOM EXPERIMENT; PHANTOM STUDIES; PLASTIC PHANTOM; PROSTATE CANCERS; PROSTATE LOCALIZATION; PROSTATE RADIOTHERAPY; SPHERICAL CAVITIES; STANDARD DEVIATION; STEREOSCOPIC IMAGING; THERAPY ASSESSMENT; WATER SOLUTIONS;

EXPERIMENTS; GOLD; MAGNETIC RESONANCE; RADIOTHERAPY; TISSUE; UROLOGY;

MAGNETIC RESONANCE SPECTROSCOPY;

CHOLINE; CITRIC ACID; CREATININE; TUMOR MARKER;

ARTICLE; FIDUCIAL MARKER; GOLD STANDARD; IMAGE QUALITY; IMAGING SYSTEM; MAGNETIC RESONANCE STEREOSCOPIC IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHANTOM; PRIORITY JOURNAL; PROSTATE;

BIOLOGICAL MARKERS; CHOLINE; CITRATES; CREATINE; FIDUCIAL MARKERS; GOLD; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; PHANTOMS, IMAGING; PROSTATE; PROSTATIC NEOPLASMS;

EID: 84862826338     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2011.06.2001     Document Type: Article

References (20)

1. H. Hricak, S. White, and D. Vigneron Carcinoma of the prostate gland: MR imaging with pelvic phased-array coils versus integrated endorectal-pelvic phased-array coils Radiology 193 1994 703 709
2. J. Kurhanewicz, D.B. Vigneron, and H. Hricak Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7 cm3) spatial resolution Radiology 198 1996 795 805
3. J.A. Jung, F.V. Coakley, and D.B. Vigneron Prostate depiction at endorectal MR spectroscopic imaging: Investigation of a standardized evaluation system Radiology 233 2004 701 708
4. J.J. Hom, F.V. Coakley, and J.P. Simko Prostate cancer: Endorectal MR imaging and MR spectroscopic imaging - distinction of true-positive results from chance detected lesions Radiology 238 2006 192 199
5. J. Scheidler, H. Hricak, and D.B. Vigneron Prostate cancer: Localization with three dimensional proton MR spectroscopic imaging: Clinicopathologic study Radiology 213 1999 473 480
6. K.K. Yu, J. Scheidler, and H. Hricak Prostate cancer: Prediction of extracapsular extension with endorectal MR imaging and three-dimensional proton MR spectroscopic imaging Radiology 213 1999 481 488
7. A.E. Wefer, H. Hricak, and D.B. Vigneron Sextant localization of prostate cancer: Comparison of sextant biopsy, magnetic resonance imaging and magnetic resonance spectroscopic imaging with step section histology J Urol 164 2000 400 404
8. F.V. Coakley, J. Kurhanewicz, and Y. Lu Prostate cancer tumor volume: Measurement with endorectal MR and MR spectroscopic imaging Radiology 223 2002 91 97
9. K.L. Zakian, K. Sircar, and H. Hricak Correlation of proton MR spectroscopic imaging with Gleason score based on step-section pathologic analysis after radical prostatectomy Radiology 234 2005 804 814
10. P. Xia, B. Pickett, and E. Vigeneault Forward or inversely planned segmental multileaf collimator IMRT and sequential tomotherapy to treat multiple dominant intraprostatic lesions or prostate cancer to 90 Gy Int J Radiat Oncol Biol Phys 51 2001 244 254
11. J. Pouliot, Y. Kim, and E. Lessard Inverse planning for HDR prostate brachytherapy used to boost dominant intraprostatic lesions defined by magnetic resonance spectroscopy imaging Int J Radiat Oncol Biol Phys 59 2004 1196 1207
12. E.N.J.T. Van Lin, J.J. Futterer, and S.W.T.P.J. Heijmink IMRT boost dose planning on dominant intraprostatic lesions: Gold marker-based three-dimensional fusion of CT with dynamic contrast-enhanced and H-spectroscopic MRI Int J Radiat Oncol Biol Phys 65 2006 291 303
13. W.U. Shipley, L.J. Verhey, and J.E. Munzenrider Advanced prostate cancer: The results of a randomized comparative trial of high dose irradiation boosting with conformal protons compared with convectional dose irradiation using photons alone Int J Radiat Oncol Biol Phys 32 1995 3 12
14. A. Pollack, G.K. Zagars, and G. Starkschall Prostate cancer radiation dose response: Results of the M. D. Anderson phase III randomized trial Int J Radiat Oncol Biol Phys 53 2002 1097 1105
15. A.L. Zietman, M.L. DeSilvio, and J.D. Slater Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: A randomized controlled trial JAMA 294 2005 1233 1239
16. F.V. Coakley, H.S. Teh, and A. Qayyum Endorectal MR imaging and MR spectroscopic imaging for locally recurrent prostate cancer after external beam radiation therapy: Preliminary experience Radiology 233 2004 441 448
17. M.J. Zelefsky, G. Cohen, and K.L. Zakian Intraoperative conformal optimization for transperineal prostate implantation using magnetic resonance spectroscopic imaging Cancer J 6 2000 249 255
18. A.J. DiBiase, K. Hoseinzadeh, and R.P. Gullapalli Magnetic resonance spectroscopic imaging-guided brachytherapy for localized prostate cancer Int J Radiat Oncol Biol Phys 52 2002 429 438
19. R. Noeske, B. Werner, and C. Ma Prostate MR spectroscopy in the presence of gold seed fiducial markers [Abstract] Proc Intl Soc Magn Reson Med 4770 2010
20. S.W. Provencher (1993) Estimation of metabolite concentrations from localized in vivo proton NMR spectra Magn Reson Med 30 1993 672 679